Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2005
12/07/2005EP1601360A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1175410B1 Pesticidal triazine derivatives
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705730A Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
12/07/2005CN1705660A New dihydro-4(1h)-pyridinone derivatives are useful in the treatment of cognitive disorders, neurodegenerative diseases and pain
12/07/2005CN1705659A Large conductance calcium-activated k channel opener
12/07/2005CN1705645A Methylene urea derivatives as raf-kinase inhibitors
12/07/2005CN1704406A Intermediate for the preparation of epimino
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230170C Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972293 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
12/01/2005WO2005113581A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005WO2005113551A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/01/2005WO2005113548A1 Thiophene heteroaryl amines
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005WO2005113531A1 Light-emitting device material and light-emitting device
12/01/2005WO2005113514A2 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
12/01/2005WO2005112932A2 Raf modulators and methods of use
12/01/2005WO2005112923A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2004108715A8 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity
12/01/2005WO2004108713A8 Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
12/01/2005WO2004101544A8 Benzyl sulfonamide derivatives as androgen receptor antagonists
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267160 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267148 Benzimidazole derivative
12/01/2005US20050267142 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors
12/01/2005US20050267139 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267138 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005US20050267089 (5-Methoxy-2-pyridin-2-yl-pyrimidin-4-yl)-(5-pyrrolidin-1-yl-pyridin-2-yl)-amine; SK channel modulators (SK=small conductance calcium activated potassium channels); antiepileptic agents; seizures; learning enhancement; cognition activators; mood/psychotic disorders; antidepressants; Parkinson's disease
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267044 Novel compounds and compositions as cathepsin S inhibitors
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005US20050266567 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
12/01/2005US20050266268 Such as bis(4-biphenyl-4-yl)pyridine-C3-N3)(acetylacetonato-) iridium (III); brightness; phosphorescence; graphic arts
12/01/2005DE102004021637A1 Dihydrobenzothiophene Dihydrobenzothiophene
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2567352A1 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005CA2567228A1 Thiophene heteroaryl amines
12/01/2005CA2566610A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
12/01/2005CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005CA2565200A1 Raf modulators and methods of use
11/2005
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
11/30/2005EP1599451A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
11/30/2005EP1599447A1 Ligands that modulate lxr-type receptors
11/30/2005EP1483246B1 5-substituted-alkylaminopyrazole derivatives as pesticides
11/30/2005EP1259485B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/30/2005EP1185518B1 Alpha-phenyl-beta-ketosulfone
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005EP1140786B1 Reductive alkylation of secondary amines with hydrosilane
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005EP0932403B1 Condensed (hetaryl-substituted) 1-benzyl-3-pyrazol derivates for treating diseases of the cardiovascular and central nervous systems
11/30/2005CN1703411A Piperidine derivatives as CCR5 inhibitors
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703402A Pyridine derivatives as CB2 receptor modulators
11/30/2005CN1703400A Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/30/2005CN1229345C N-(indolcarbonyl) piperazin derivatives
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/30/2005CN1229329C Substituted amino amide salicylate with fungal killing function and its prepared intermediate thereof
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969770 reacting an alpha-keto carboxy acid ester or derivative with a pyrrolidinone to form an intermediate, subjecting the intermediate to asymmetric hydrogenation using a chiral catalyst to form the end product
11/29/2005US6969730 Amines as histamine-3 receptor ligands and their therapeutic applications
11/29/2005US6969728 Antiinflammatory agents
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969710 Compounds
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2244245C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 523